Larry R. McLean

3.2k total citations · 1 hit paper
47 papers, 2.6k citations indexed

About

Larry R. McLean is a scholar working on Molecular Biology, Organic Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Larry R. McLean has authored 47 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 9 papers in Organic Chemistry and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Larry R. McLean's work include Lipid Membrane Structure and Behavior (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Lipid metabolism and biosynthesis (6 papers). Larry R. McLean is often cited by papers focused on Lipid Membrane Structure and Behavior (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Lipid metabolism and biosynthesis (6 papers). Larry R. McLean collaborates with scholars based in United States, Netherlands and France. Larry R. McLean's co-authors include John T. Pelton, Michael C. Phillips, Karen A. Hagaman, Lawrence P. Aggerbeck, John R. Wetterau, John L. Krstenansky, Henry M. Laboda, Sissel Lund‐Katz, Richard L. Jackson and Kelly A. Combs and has published in prestigious journals such as Biochemistry, Analytical Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Larry R. McLean

47 papers receiving 2.5k citations

Hit Papers

Spectroscopic Methods for Analysis of Protein Secondary S... 2000 2026 2008 2017 2000 250 500 750

Peers

Larry R. McLean
Gary E. Means United States
David N. Brems United States
Joanna E. Burdette United States
B. S. Hartley United Kingdom
Gary E. Means United States
Larry R. McLean
Citations per year, relative to Larry R. McLean Larry R. McLean (= 1×) peers Gary E. Means

Countries citing papers authored by Larry R. McLean

Since Specialization
Citations

This map shows the geographic impact of Larry R. McLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry R. McLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry R. McLean more than expected).

Fields of papers citing papers by Larry R. McLean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry R. McLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry R. McLean. The network helps show where Larry R. McLean may publish in the future.

Co-authorship network of co-authors of Larry R. McLean

This figure shows the co-authorship network connecting the top 25 collaborators of Larry R. McLean. A scholar is included among the top collaborators of Larry R. McLean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry R. McLean. Larry R. McLean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaz, Roy J., Yi Li, Stephan Reiling, et al.. (2018). Amelioration of PXR-mediated CYP3A4 induction by mGluR2 modulators. Bioorganic & Medicinal Chemistry Letters. 28(19). 3194–3196. 10 indexed citations
2.
McLean, Larry R., Ying Zhang, Jane Peppard, et al.. (2010). Discovery of novel inhibitors for DHODH via virtual screening and X-ray crystallographic structures. Bioorganic & Medicinal Chemistry Letters. 20(6). 1981–1984. 17 indexed citations
3.
McLean, Larry R., et al.. (2010). Fragment screening of inhibitors for MIF tautomerase reveals a cryptic surface binding site. Bioorganic & Medicinal Chemistry Letters. 20(6). 1821–1824. 26 indexed citations
4.
McLean, Larry R., Ying Zhang, Hua Li, et al.. (2009). Discovery of covalent inhibitors for MIF tautomerase via cocrystal structures with phantom hits from virtual screening. Bioorganic & Medicinal Chemistry Letters. 19(23). 6717–6720. 35 indexed citations
5.
Pelton, John T. & Larry R. McLean. (2000). Spectroscopic Methods for Analysis of Protein Secondary Structure. Analytical Biochemistry. 277(2). 167–176. 998 indexed citations breakdown →
6.
McLean, Larry R. & Jon Lewis. (1994). Biomimetic pulmonary surfactants. Life Sciences. 56(6). 363–378. 10 indexed citations
7.
McLean, Larry R. & Karen A. Hagaman. (1993). Kinetics of the interaction of amphipathic α-helical peptides with phosphatidylcholines. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1167(3). 289–295. 4 indexed citations
8.
McLean, Larry R., Jon Lewis, Karen A. Hagaman, Thomas J. Owen, & Richard L. Jackson. (1993). Amphipathic α-helical peptides based on surfactant apoprotein SP-A. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1166(1). 31–38. 9 indexed citations
9.
McLean, Larry R., Jon Lewis, John L. Krstenansky, et al.. (1993). An Amphipathic α-Helical Decapeptide in Phosphatidylcholine Is an Effective Synthetic Lung Surfactant. American Review of Respiratory Disease. 147(2). 462–465. 23 indexed citations
10.
McLean, Larry R. & A. Balasubramaniam. (1992). Promotion of β-structure by interaction of diabetes associated polypeptide (amylin) with phosphatidylcholine. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1122(3). 317–320. 32 indexed citations
11.
Diccianni, Mitchell B., et al.. (1991). Porcine pancreatic phospholipase A2 isoforms: differential regulation by heparin. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1082(1). 85–93. 6 indexed citations
12.
McLean, Larry R., Karen A. Hagaman, Thomas J. Owen, & John L. Krstenansky. (1991). Minimal peptide length for interaction of amphipathic .alpha.-helical peptides with phosphatidylcholine liposomes. Biochemistry. 30(1). 31–37. 80 indexed citations
13.
Wetterau, John R., et al.. (1991). Protein disulfide isomerase appears necessary to maintain the catalytically active structure of the microsomal triglyceride transfer protein. Biochemistry. 30(40). 9728–9735. 174 indexed citations
14.
McLean, Larry R., Stephen H. Buck, & John L. Krstenansky. (1990). Examination of the role of the amphipathic .alpha.-helix in the interaction of neuropeptide Y and active cyclic analogs with cell membrane receptors and dimyristoylphosphatidylcholine. Biochemistry. 29(8). 2016–2022. 50 indexed citations
15.
McLean, Larry R., et al.. (1990). Lipid and membrane interactions of neuropeptide Y. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1024(1). 1–4. 18 indexed citations
16.
McLean, Larry R. & Karen A. Hagaman. (1990). Antioxidant activity of probucol and its effects on phase transitions in phosphatidylcholine liposomes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1029(1). 161–166. 11 indexed citations
17.
McLean, Larry R. & Karen A. Hagaman. (1989). Effect of probucol on the physical properties of low-density lipoproteins oxidized by copper. Biochemistry. 28(1). 321–327. 77 indexed citations
18.
McLean, Larry R., John L. Krstenansky, Thomas J. Owen, Maurice R. Eftink, & Karen A. Hagaman. (1989). Effect of micelle diameter on tryptophan dynamics in an amphipathic helical peptide in phosphatidylcholine. Biochemistry. 28(21). 8403–8410. 10 indexed citations
19.
McLean, Larry R., et al.. (1988). Red blood cell membrane microviscosity correlates with posttransfusion survival. Biochemical and Biophysical Research Communications. 154(1). 387–391. 6 indexed citations
20.
Lund‐Katz, Sissel, Henry M. Laboda, Larry R. McLean, & Michael C. Phillips. (1988). Influence of molecular packing and phospholipid type on rates of cholesterol exchange. Biochemistry. 27(9). 3416–3423. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026